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ABSTRACT
Purpose: Angiogenesis involves many mediators including integrins, and the tripeptide RGD is a target amino acid recognition
sequence for many of them. Hindlimb ischemia is a simple and convenient animal model however standardization of the injection
procedures in the devascularized and control limb is lacking, thus rendering difficult the interpretation of results. The aim of
this investigations was to evaluate neovascularization in a hindlimb murine model by means of 99mTc-HYNIC-ß-Ala-RGD.
Methods: 99mTc-HYNIC-RGD analog was prepared using coligands. Ischemia was induced in Wistar rats by double- ligation of the
common femoral artery. Radiolabeled RGD was injected after 2h, as well as 1, 3, 5, 7, 10 and 14 days. Uptake was evaluated by planar
imaging and biodistribution studies. Results: The highest ratio between ischemia and control was achieved at the 7th day (2.62 ± 0.95),
with substantial decrease by the 14th day. For pertechnetate the 7th day ratio was 0.87 ± 0.23. Scintigraphic image confirmed different
uptakes. Conclusion: 99mTc-HYNIC-RGD analog concentrated in ischemic tissue by the time of widespread angiogenesis and
pertechnetate confirmed reduction in blood flow. In this sense, the protocol can be recommended for ischemic models.
Key words: Technetium. Isotope Labeling. Radionuclide Imaging. Ischemia. Diagnosis. Rats.
RESUMO
Objetivo: A angiogênese em resposta a fenômenos isquêmicos envolve vários mediadores como as integrinas, sendo que o tripeptídeo
RGD possui uma seqüência de aminoácidos com reconhecimento para este alvo. O modelo animal de isquemia de pata traseira é
simples e conveniente, porém não há uma padronização do procedimento de injeção e controle radioisotópico em membro
desvascularizado, dificultando, portanto a interpretação de resultados. O objetivo deste estudo foi avaliar a neovascularização em modelo
murino de isquemia de pata traseira através do radiotraçador 99mTc-HYNIC-ß-Ala-RGD. Métodos: O análogo 99mTc-HYNIC-RGD foi
preparado usando coligantes. A isquemia foi induzida em ratos Wistar por dupla-ligação da artéria femoral comum na prega inguinal.
Peptídeo RGD radiomarcado foi injetado após 2h, assim como 1, 3, 5, 7, 10 e 14 dias. A captação foi avaliada por imagem planar e
estudos de biodistribuição. Resultados: A maior diferença de captação entre isquemia e pata controle foi obtida no 7o dia (2,62 ±  0,95),
com decréscimo acentuado no 14o dia. Para o pertecnetato a razão no 7o dia foi 0,87 ± 0,23. A imagem cintilográfica confirmou as
diferentes captações. Conclusões: O análogo 99mTc-HYNIC-RGD concentrou-se no tecido isquêmico na etapa em que a angiogênese é
mais acentuada, e o estudo do pertecnetato confirmou a redução no fluxo sanguíneo. Desta maneira, este protocolo diagnóstico pode
ser recomendado para modelos isquêmicos.
Descritores: Tecnécio. Marcação por Isótopo. Cintilografia. Isquemia. Diagnóstico. Ratos.
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Introduction
Several partially overlapping definitions apply to the
development of blood vessels. Neovascularization is the broad
physiological response to ischemia and corresponds to blood flow
recovery detected in vivo.
Angiogenesis is not only involved in cancer progression
but also plays an important role in the improvement and healing
of ischemic lesions1. It is a complex process involving many
components as integrins.
Integrins are a notable class of receptor proteins, from
the large family of cell adhesion receptors which are involved in
cell-extracellular matrix and cell-cell interactions2.
They consist of two transmembrane glycoproteins
represented by non-covalently associated Į and ß-units, which are
essential for the healing of ischemic lesions. Accordingly, elevated
DvE3  integrin expression has been observed in ischemic tissue of
the brain, ophthalmological diseases, and muscles3.
A majority of integrins, including the DvE3 unit, recognize
a conserved amino acid sequence, arginine-glycine-aspartic acid
(Arg-Gly-Asp or RGD).
Many of the first generation of RGD peptides were
low-binding DvE3 integrins, because the molecule was linear and
highly susceptible to chemical degradation. That occured due to
reaction of the aspartic acid residue with the peptide backbone.
Cyclization of the molecule conferred rigidity to the structure
improving binding properties, and may serve as a vehicle to carry
radionuclides to the integrin DvE3.
RGD analogs have been radiolabeled with different
radioisotopes, including, iodine-123 copper-64, indium-111,
fluorine-18, technetium-99m, yttrium-90, bromine-76, with the scope
of achieving a radiopharmaceutical targeted for angiogenesis
processes in both tumors and regenerative neovascularization4,5.
Technetium-99m (99mTc) has the advantage of optimal
nuclear properties (6h half-life and monochromatic 140 keV
photons), along with favorable logistics, being transportable and
easily available from 99Mo/99mTc generators at low cost. The
labeling was performed using the precursors 99mTc-nitrido and
99mTc- tricarbonyl6 as well as BFCA 2-hydrazino-nicotinic acid
(HYNIC)4,7.
The most common approach for designing a target-
specific 99mTc agent has been to attach a chelating group to a
bioactive molecule, resulting in a combined ligand that can form a
complex with 99mTc in a reduced oxidation state. This procedure is
commonly known as a bifunctional approach, and the specific
ligands employed as bifunctional chelating agents (BFCAs).
HYNIC has been reported as a BFCA of great interest
due to its high efficiency, fast radiolabeling and high
radiolabeling yield7.
The molecule used in the current study is the integrin
DvE3-targeted radiotracer composed of a targeting biomolecule,
cyclic RGD peptide (RGDyK), and a radiometal chelate. The lysine
residue (K) serves as an ideal building block for further chemical
conjugation reactions8. For the molecule containing radiotracer,
a BFCA (HYNIC) was used to attach the metallic radionuclide
(Figure 1).
FIGURE 1 – Scheme of HYNIC-RGDyK conjugation.
The animal ischemic hindlimb technique has been often
employed in neovascularization9, and other vascular investigations,
even though results are occasionally questioned on account of
inadequate standardization of the procedure10.
The aim of this investigations was the use 99mTc-HYNIC-
ß-Ala-RGD as a diagnostic radiotracer to evaluate
neovascularization in the extended period of 14 days, in a hindlimb
murine model with double arterial ligation.
Methods
Conventional reagents were purchased from Merck,
Brazil and Sigma-Aldrich, Brazil, unless otherwise stated, and
were used without further purification.
- HYNIC-RGD derivative was synthesized by
Biosynthan, Berlin, Germany.
- 99Mo/99mTc generator: it is routinely manufactured and
made available by the Institute of Energetic and Nuclear Research
(IPEN-CNEN/Sao Paulo, Brazil).
- Animals for imaging and biodistribution studies: Wistar
rats were supplied by the animal facility of IPEN-CNEN/Sao Paulo,
Brazil
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Labeling procedure using EDDA/tricine as exchange
products
HYNIC-Peptide labeling procedure was reported before7.
Briefly, to a sealed reaction vial containing 20 mg Tricine and
5 mg of EDDA it was added 0.5 mL of 0.1M phosphate buffer
solution, previously nitrogenated, for the dissolution of the salts.
Then 10 µl of a solution 1.32 mM of  [c[Arg-Gly-Asp-D-Tyr-
(HYNIC)-Lys] plus 5 µL of  8.9 mM SnCl2.H2O solution in 0.1N
HCl (nitrogen-purged) and 500 µL of Na99mTcO4 was added.  The
mixture was heated for 15 minutes in water bath at 100oC and
cooled to room temperature; the pH of the reaction was 7.
Radiochemical control
Radiochemical analysis of  99mTc-HYNIC-RGDyK  was
performed by thin-layer chromatography (TLC) on silica gel strips
(ITLC-SG, Gelman Sciences, Ann Arbor, MI) using a two solvent
system, namely methylethylketone (MEK) for detection of
99mTcO4- and 50% Acetonitrile (ACN) for 
99mTcO2.
Radiolabeled conjugate was also characterized by Reverse
Phase-High Performance Liquid Chromatography (RP-HPLC).
This analysis was performed on a Waters 600E system equipped
with a Waters 486 tunable absorbance detector, an in-line Packard
150TR flow scintillation analyzer, and a Waters 746 data module.
HPLC solvents consisted of H2O containing 0.1% trifluoroacetic
acid (Solvent A) and acetonitrile containing 0.1% trifluoracetic
acid (Solvent B).  A Symmetry C-18 column (5.0 µm, 100 Å,
4.6 x 250 mm, Waters, Milford, MA) was used with a flow rate of
0.5 ml/min.  The HPLC gradient system began with a solvent
composition of 95% A and 5% B and followed a linear gradient
of 30%A:70%B from 0-25 min, and 30%A:70%B to
5%A:95%B from 25-30 min.
Biological studies
The study was approved by the institutional Animal
Welfare Committee, and all procedures were conducted in
agreement with the principles of the Brazilian College of Animal
Experimentation. The in vivo studies were performed in male
Wistar rats submitted to common femoral artery double occlusion.
The study was performed in groups of 6 animals for each time
studied.
Surgical technique
The animals were anesthetized (1 mL/Kg IP ketamine
and 0.5 ml/Kg IP xylazine) and shaved for surgical intervention.
The right femoral vessels were exposed through an inguinal skin
incision, and the common femoral artery was carefully separated
and double-ligated (Figure 2). The first ligation was done at the
common artery proximal to the bifurcation of the deep femoral
artery and a second ligation followed on the superficial artery
below the bifurcation (Figure 3). After the incision was sutured
rats were allowed to recover. By 2h and after 1, 3, 5, 7, 10 and 14
days the radiolabeled peptide was injected.
FIGURE 2 – Femoral artery occlusion procedure.
FIGURE 3 – Schematic illustration of femoral artery occlusion10.
Biodistribution study and imaging evaluation
Each animal was injected with 0.1 mL of 99mTc-HYNIC-
RGD analog via the tail vein. The animals were sacrificed 2 hours
post-injection. Evaluation of the uptake by the ischemic limb and
normal contralateral limb was done on each occasion. Hindlimb
pertechnetate, which has no affinity for regenerating tissue and in
the circumstances indicates just blood flow, was also registered
for confirmation.
Complete biodistribution assessment was done 7 days
after the surgical procedure. The animals were sacrificed by
cervical dislocation, and tissues and organs were excised,
weighted and radioactivity measured in a gamma counter
(Cobra 5002, Packard, USA), using the injected dose as standard
for calculation. Results were expressed in percentage of injected
dose per gram (%ID/g).
For acquisition of images the rats were anesthetized and
horizontally placed under the collimator of a Mediso Imaging
System, Budapest, Hungria, employing a LEHR collimator.
Images were acquired at 2h post injection using a 256 x 256 x 16
matrix size with a 20% energy window set at 140 keV for a period
of 180 seconds.
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Ratio between homologous images of the same animal
was calculated by means of the Region of Interest (ROI)
technique.
Statistical analysis
Discrepancies among the uptakes ratios between of
99mTc-HYNIC-RGD in ischemic hindlimbs and control side at
different times were analyzed by Statgraphics Plus 5.0 (Statistical
Graphics Corp., Fairfax, Va., U.S.A.). One-way analysis of
variance (ANOVA) followed by post-hoc Tukey test were
performed. The adopted significance level (Į ) was P<0.05.
Results
Labeling procedure using EDDA/tricine as exchange
products
The conjugate HYNIC-RGDyK was radiolabeled using
the exchange labeling technology via tricine and EDDA.
Radiochemical purity of 99mTc-HYNIC-RGD was
99.45 ± 0.12%. TLC findings were confirmed by HPLC
(Figure 4) with a retention time for the product of 12.86 minutes.
Only traces (< 0.6 %) of 99mTcO4- could be detected, with a
retention time of  5.33 min. Specific activity was 142.3 MBq/nmol.
FIGURE 5 – Uptake of 99mTc-HYNIC-RGD analog in tissues/organs.
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FIGURE 4 – Radio-HPLC elution profile of 99mTc-HYNIC-RGDyK.
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Hindlimb uptake of 99mTc-HYNIC-RGD can be observed
in Table 1. The highest ratio between ischemic hindlimb and
control side was achieved at the 7th day (2.62 ± 0.33), with
substantial decrease by the 14th day (0.30 ± 0.02). This result was
statistically confirmed by one way ANOVA (p=6.24 x 10-24< 0.05)
and Tukey test.
Pertchnetate uptake in both hindlimbs (control and
devascularized), was also documented as a control and the ratio
for the 7th day was 0.87 ± 0.23.
Biodistribution studies
Biodistribution of 99mTc-HYNIC-RGD analog was
expressed in %ID/g (Figure 5). Uptake was ordinarily below
1.0 %ID/g. The best values corresponded to kidneys (2.30 ±
0.26 %ID/g), liver, intestine and spleen. Blood uptake (0.07 ±
0.01% ID/mL) showed a good clearance of the radiotracer.
TABLE 1 – Uptake of 99mTc-HYNIC-RGD in hindlimbs.
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The images of pertechnetate (A) and 99mTc-HYNIC-RGD
(B) in hindlimbs can be observed in Figure 6. Pertechnetate as
a nonspecific marker for new vascularization, didn’t show
differences between hindlimbs. Ratio of ischemic to normally-
Discussion
The major triggers of angiogenesis process can be
simplified into three broad categories: mechanical, chemical,
and molecular factors8. Molecular mediators are not necessarily
abundant or present in all phases of the process, but they are
specific and can be monitored by radiotracers using imaging or
non-imaging techniques.
There are several advantages in using radiolabeled
small RGD peptides as radiotracers. They can tolerate harsh
conditons for radiolabeling and chemical modification due their
small size and rapid blood clearance.
The molecule containing the cyclic sequence RGD
usually is designed with more amino acids as fK, fV or yK4,
besides those molecules that compose the multimeric structure
to allow the labeling with the radionuclide.
To the sequence RGD it was here added two amino
acids, D-Tyrosine and Lysine. Non-natural peptide modifications
such as the introduction of D-amino acids, as well as replacement
with peptidomimetic structures, tend to grant RGD peptide ligands
increased specificity and nanomolar or at least higher affinity.
The radiolabeling of RGD analog using HYNIC as
BFCA was easy and quick to perform. Most importantly, it was
associated with a high yield and no purification step was needed,
so that the radiocompound could be injected right away.
Technetium-99m binds to the hydrazine-moiety forming
a 99mTc-N bond. As HYNIC alone cannot satisfy the coordination
requirements of Tc(V) because it occupies one or two coordination
sites on the radionuclide, coligands are necessary to complete the
coordination sphere of the technetium (V) core.
We had reported before7 that conjugates prepared by
tricine/EDDA exchange labeling exhibit high specific activity and
excellent radiochemical stability.
perfused hindlimb in the images (B) (2.51), estimated by drawing
regions of interest, did not yield much additional information.
General values were of the same range as shown by gamma-
counter.
FIGURE 6 – (A) Scintigraphic images of Na99mTcO4. (B) 
99mTc-HYNIC-RGDyK in ischemic hindlimbs rats on day 7.
Biodistribution in tissues and organs showed the highest
uptake by the kidneys reflecting a renal excretion, followed by
liver, intestine and spleen.
Major murine organs, such as liver, spleen and colon
showed specific uptake suggesting DvE3 expression in these
tissues as announced before by Dijkgraaf et al.2.
The highest uptake ratio of 99mTc-HYNIC-RGD between
ischemic hindlimb and control side was achieved at the 7th day,
decreasing in later days probably due to attenuation of the
angiogenesis phenomenon.
Lee et al.11 labeled HYNIC-c(RGDyK) with 18F reported
that  the vascular endothelial growth factor protein expression
was maximum on day 7.
Also Hua et al.12 achieved results compatible with ours
using 99mTc-NC100692. Their studies were conducted in mice with
NC100692, a product from “Amersham” in which the sequence
of amino acids RGD is held in a cycle by a disulphide and a
thioether bridge, with a short polyethylene glycol unit. Edwards
et al.13 used the same radiotracer, 99mTc-NC100692, to document
the dissociation constant [Kd] for integrin receptors.
For pertechnetate a low ratio was registered because as a
passive marker, it does not bind to new blood vessels, confirming
just blood flow. The importance of such procedure has not been
emphasized in other protocols. The ratio obtained for the 7th day
was 0.87 ± 0.23, consistent with reduced perfusion following
arterial ligation.
Experimental methods to create hindlimb ischemia are
not standardized. Goto et al.10 described a number of methods to
create stable hindlimb ischemia in the mouse by occluding the
artery, varying from simple ligation, to cutting, or to excision of
the artery. The targeted vessel could be the iliac artery, the femoral
artery, or the femoral and saphenous trunks. We opted to execute
the ligation of the femoral artery in two sites, encompassing
(A) (B)
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both the common and superficial artery. This modality was easy,
convenient and moderately reproducible.
Skjeldal et al.14 reported that, small animals as like mice
are endowed with a well-developed innate collateral system, and
thus display remarkably high resistance to ischemia. Simple
ligation of the femoral artery is known to produce no severe
ischemic change.
Within in this context, the animal used in the study (Wistar
rats) was not ideal due the well-developed collateral circulation in
hindlimb. We achieved only 70% of reproducibility of the model.
The weak image contrast between ischemic and
contralateral hindlimb with 99mTc-HYNIC-RGD is partly due
to residual muscle uptake. It does not coincidence with
biodistribution results and needs to be improved.
In synthesis, radiotracer assessment demonstrated
somewhat less angiogenesis than anticipated. Lee et al.15,
employing laser Doppler flowmetry on days 3 and 8 of ischemia,
with 125I-c(RGD(I)yV) and then RGD analog labeled with 123I for
scintigraphy, were also disappointed by relatively modest image
contrast between the hindlimbs.
Conclusions
99mTc-HYNIC-RGD analog corresponded to expectations,
displaying elevated uptake in ischemic tissue by the time of
widespread angiogenesis. The animal model showed only 70%
of reproducibility. Utilization in other ischemic models can be
recommended. The modest image obtained with 99mTc-HYNIC-
RGD does not correspond to a previous result in biodistribution
and needs to be improved.
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